APO Research
Talk to an analyst

APO RESEARCH · REPORT

Basiliximab Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Basiliximab Injection Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchBasiliximab Injection Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Basiliximab Injection Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Basiliximab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Basiliximab Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Basiliximab Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Basiliximab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Basiliximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Basiliximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Basiliximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Basiliximab Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Basiliximab Injection market include Novartis AG and Ryvis Pharma among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Basiliximab Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Basiliximab Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Basiliximab Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Basiliximab Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Basiliximab Injection Segment by Company

Novartis AG

Ryvis Pharma

Basiliximab Injection Segment by Type

20 mL

10 mL

Basiliximab Injection Segment by Application

Adult Use

Pediatric Use

Basiliximab Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Basiliximab Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Basiliximab Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Basiliximab Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Basiliximab Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Basiliximab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Basiliximab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Basiliximab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Basiliximab Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Basiliximab Injection industry.

Chapter 3: Detailed analysis of Basiliximab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Basiliximab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Basiliximab Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Basiliximab Injection Industry Trends Table 2. Basiliximab Injection Industry Drivers Table 3. Basiliximab Injection Industry Opportunities and Challenges Table 4. Basiliximab Injection Industry Restraints Table 5. Global Basiliximab Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Basiliximab Injection Revenue Share by Company (2021-2026) Table 7. Global Basiliximab Injection Sales Volume by Company (K L) & (2021-2026) Table 8. Global Basiliximab Injection Sales Volume Share by Company (2021-2026) Table 9. Global Basiliximab Injection Average Price (US$/L) of Company (2021-2026) Table 10. Global Basiliximab Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Basiliximab Injection Key Company Manufacturing Base & Headquarters Table 12. Global Basiliximab Injection Company, Product Type & Application Table 13. Global Basiliximab Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Basiliximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20 mL Table 18. Significant Companies of 10 mL Table 19. Global Basiliximab Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K L) Table 20. Global Basiliximab Injection Sales Volume by Type (2021-2026) & (K L) Table 21. Global Basiliximab Injection Sales Volume by Type (2027-2032) & (K L) Table 22. Global Basiliximab Injection Sales Volume Share by Type (2021-2026) Table 23. Global Basiliximab Injection Sales Volume Share by Type (2027-2032) Table 24. Global Basiliximab Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Basiliximab Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Basiliximab Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Basiliximab Injection Sales Value Share by Type (2021-2026) Table 28. Global Basiliximab Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adult Use Table 30. Significant Companies of Pediatric Use Table 31. Global Basiliximab Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K L) Table 32. Global Basiliximab Injection Sales Volume by Application (2021-2026) & (K L) Table 33. Global Basiliximab Injection Sales Volume by Application (2027-2032) & (K L) Table 34. Global Basiliximab Injection Sales Volume Share by Application (2021-2026) Table 35. Global Basiliximab Injection Sales Volume Share by Application (2027-2032) Table 36. Global Basiliximab Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Basiliximab Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Basiliximab Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Basiliximab Injection Sales Value Share by Application (2021-2026) Table 40. Global Basiliximab Injection Sales Value Share by Application (2027-2032) Table 41. Global Basiliximab Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 42. Global Basiliximab Injection Sales by Region (2021-2026) & (K L) Table 43. Global Basiliximab Injection Sales Market Share by Region (2021-2026) Table 44. Global Basiliximab Injection Sales by Region (2027-2032) & (K L) Table 45. Global Basiliximab Injection Sales Market Share by Region (2027-2032) Table 46. Global Basiliximab Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Basiliximab Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Basiliximab Injection Sales Value Share by Region (2021-2026) Table 49. Global Basiliximab Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Basiliximab Injection Sales Value Share by Region (2027-2032) Table 51. Global Basiliximab Injection Market Average Price (US$/L) by Region (2021-2026) Table 52. Global Basiliximab Injection Market Average Price (US$/L) by Region (2027-2032) Table 53. Global Basiliximab Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Table 54. Global Basiliximab Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Basiliximab Injection Sales by Country (2021-2026) & (K L) Table 56. Global Basiliximab Injection Sales Market Share by Country (2021-2026) Table 57. Global Basiliximab Injection Sales by Country (2027-2032) & (K L) Table 58. Global Basiliximab Injection Sales Market Share by Country (2027-2032) Table 59. Global Basiliximab Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Basiliximab Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Basiliximab Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Basiliximab Injection Sales Value Market Share by Country (2027-2032) Table 63. Novartis AG Company Information Table 64. Novartis AG Business Overview Table 65. Novartis AG Basiliximab Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 66. Novartis AG Basiliximab Injection Product Portfolio Table 67. Novartis AG Recent Development Table 68. Ryvis Pharma Company Information Table 69. Ryvis Pharma Business Overview Table 70. Ryvis Pharma Basiliximab Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 71. Ryvis Pharma Basiliximab Injection Product Portfolio Table 72. Ryvis Pharma Recent Development Table 73. Key Raw Materials Table 74. Raw Materials Key Suppliers Table 75. Basiliximab Injection Distributors List Table 76. Basiliximab Injection Customers List Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Basiliximab Injection Product Image Figure 2. Global Basiliximab Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Basiliximab Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Basiliximab Injection Sales (2021-2032) & (K L) Figure 5. Global Basiliximab Injection Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Basiliximab Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20 mL Image Figure 10. 10 mL Image Figure 11. Global Basiliximab Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K L) Figure 12. Global Basiliximab Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Basiliximab Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Basiliximab Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Basiliximab Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Basiliximab Injection Sales Value Share by Type (2021-2032) Figure 17. Adult Use Image Figure 18. Pediatric Use Image Figure 19. Global Basiliximab Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K L) Figure 20. Global Basiliximab Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Basiliximab Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Basiliximab Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Basiliximab Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Basiliximab Injection Sales Value Share by Application (2021-2032) Figure 25. Global Basiliximab Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 26. Global Basiliximab Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Basiliximab Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Basiliximab Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Basiliximab Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Basiliximab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Basiliximab Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Basiliximab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Basiliximab Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Basiliximab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Basiliximab Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Basiliximab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Basiliximab Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Basiliximab Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Basiliximab Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Basiliximab Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Basiliximab Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Basiliximab Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Basiliximab Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mL
  • 10 mL
Applications
  • Adult Use
  • Pediatric Use
Companies covered
  • Novartis AG
  • Ryvis Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Basiliximab Injection Sales Value (2021-2032)
  4. 1.2.2 Global Basiliximab Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Basiliximab Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Basiliximab Injection Market Dynamics
  1. 2.1 Basiliximab Injection Industry Trends
  2. 2.2 Basiliximab Injection Industry Drivers
  3. 2.3 Basiliximab Injection Industry Opportunities and Challenges
  4. 2.4 Basiliximab Injection Industry Restraints
3 Basiliximab Injection Market by Company
  1. 3.1 Global Basiliximab Injection Company Revenue Ranking in 2025
  2. 3.2 Global Basiliximab Injection Revenue by Company (2021-2026)
  3. 3.3 Global Basiliximab Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Basiliximab Injection Average Price by Company (2021-2026)
  5. 3.5 Global Basiliximab Injection Company Ranking (2024-2026)
  6. 3.6 Global Basiliximab Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Basiliximab Injection Company Product Type and Application
  8. 3.8 Global Basiliximab Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Basiliximab Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Basiliximab Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Basiliximab Injection Market by Type
  1. 4.1 Basiliximab Injection Type Introduction
  2. 4.1.1 20 mL
  3. 4.1.2 10 mL
  4. 4.2 Global Basiliximab Injection Sales Volume by Type
  5. 4.2.1 Global Basiliximab Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Basiliximab Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Basiliximab Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Basiliximab Injection Sales Value by Type
  9. 4.3.1 Global Basiliximab Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Basiliximab Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Basiliximab Injection Sales Value Share by Type (2021-2032)
5 Basiliximab Injection Market by Application
  1. 5.1 Basiliximab Injection Application Introduction
  2. 5.1.1 Adult Use
  3. 5.1.2 Pediatric Use
  4. 5.2 Global Basiliximab Injection Sales Volume by Application
  5. 5.2.1 Global Basiliximab Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Basiliximab Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Basiliximab Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Basiliximab Injection Sales Value by Application
  9. 5.3.1 Global Basiliximab Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Basiliximab Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Basiliximab Injection Sales Value Share by Application (2021-2032)
6 Basiliximab Injection Regional Sales and Value Analysis
  1. 6.1 Global Basiliximab Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Basiliximab Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Basiliximab Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Basiliximab Injection Sales by Region (2027-2032)
  5. 6.3 Global Basiliximab Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Basiliximab Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Basiliximab Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Basiliximab Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Basiliximab Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Basiliximab Injection Sales Value (2021-2032)
  12. 6.6.2 North America Basiliximab Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Basiliximab Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Basiliximab Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Basiliximab Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Basiliximab Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Basiliximab Injection Sales Value (2021-2032)
  21. 6.9.2 South America Basiliximab Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Basiliximab Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Basiliximab Injection Sales Value Share by Country, 2025 VS 2032
7 Basiliximab Injection Country-level Sales and Value Analysis
  1. 7.1 Global Basiliximab Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Basiliximab Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Basiliximab Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Basiliximab Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Basiliximab Injection Sales by Country (2027-2032)
  6. 7.4 Global Basiliximab Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Basiliximab Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Basiliximab Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Basiliximab Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Basiliximab Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Basiliximab Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Basiliximab Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Basiliximab Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Basiliximab Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Basiliximab Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Basiliximab Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Basiliximab Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Basiliximab Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Basiliximab Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Basiliximab Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Basiliximab Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Basiliximab Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Basiliximab Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Basiliximab Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Basiliximab Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Basiliximab Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Basiliximab Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Basiliximab Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Basiliximab Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Basiliximab Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Basiliximab Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Basiliximab Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Basiliximab Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Basiliximab Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Basiliximab Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Basiliximab Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Basiliximab Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Basiliximab Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Basiliximab Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Basiliximab Injection Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Ryvis Pharma
  8. 8.2.1 Ryvis Pharma Company Information
  9. 8.2.2 Ryvis Pharma Business Overview
  10. 8.2.3 Ryvis Pharma Basiliximab Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ryvis Pharma Basiliximab Injection Product Portfolio
  12. 8.2.5 Ryvis Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Basiliximab Injection Value Chain Analysis
  2. 9.1.1 Basiliximab Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Basiliximab Injection Sales Mode & Process
  6. 9.2 Basiliximab Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Basiliximab Injection Distributors
  9. 9.2.3 Basiliximab Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst